Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Molecular Diagnostics
Sherlock Biosciences acquires Sense Biodetection to drive CRISPR-based test adoption
The acquisition enables Sherlock to combine its CRISPR, synthetic biology, and artificial intelligence technologies with Sense's instrument-free diagnostic hardware and rapid molecular amplification chemistries.
February 1, 2023
Widespread resistance to last-resort antibiotic spurs development of new assay
Scientists in Germany are developing an assay to detect resistance levels and thereby reduce the frequency of therapeutic failures when using colistin to treat infections with Enterobacter.
January 30, 2023
VieCure, Labcorp collaborate on clinical workflows, genomic testing
The firms are aiming to assist patient-specific treatment plans by integrating Labcorp’s precision medicine testing with VieCure’s clinical decision-support tool.
January 25, 2023
Geneseeq nabs CE Marks for minimal residual disease, early cancer detection tests
The firm has received CE Marks for liquid biopsy multicancer minimal residual disease detection and multicancer early detection kits to detect patients with solid tumors.
January 24, 2023
AI tool makes speedy gene-editing possible, offers alternative to CRISPR
An artificial intelligence program may enable the first simple production of customizable proteins called zinc fingers to treat diseases by turning genes on and off.
January 26, 2023
Geneoscopy applies for FDA approval of at-home CRC screening test
The premarket approval submission is based on results from a pivotal clinical trial in which Geneoscopy's test showed 94% sensitivity in detecting colorectal cancer and 45% sensitivity in detecting advanced adenomas.
January 24, 2023
Most Popular
Quest Diagnostics Q4 revenues down 15% on COVID testing but base business grew
In pilot study, liquid biopsy test differentiates between localized and metastatic cancer to inform tailored treatment
SD Biosensor, SJL Partners complete acquisition of Meridian Bioscience
Roche reports flat diagnostics revenue growth for 2022
French point-of-care testing firm Biosynex to acquire Chembio Diagnostics for $17.2M
OIG report outlines challenges with CDC-supported COVID-19 vaccination programs
Thermo Fisher Scientific, AstraZeneca to develop solid tissue and blood-based CDx for NSCLC
The companion diagnostic leverages Thermo Fisher’s Oncomine Dx Express Test on its Genexus Dx System, a fully integrated next-generation sequencing platform, with an automated specimen-to-report workflow that provides results in 24 hours.
January 24, 2023
Thermo Fisher Scientific launches sequencing assay to ID variants that may resist HIV therapies
The assay, which uses HIV RNA extracted from plasma or dried blood spots, is designed to analyze genomic mutations in the protease, reverse transcriptase, and integrase regions of the HIV-1 pol gene across nine subtypes of global significance.
January 24, 2023
Qiagen Digital Insights launches NGS analysis to process whole genome for $1 in cloud computing costs
The product incorporates a software accelerator that quickly converts raw sequencing data in FASTQ files from any paired-end short-read sequencing platform into interpretable lists of genetic variants in the VCF format.
January 23, 2023
DNA sequencing method offers peek into genomic black box
University of Cambridge researchers have outlined a new DNA sequencing method that detects where and how small molecule drugs interact with a targeted genome.
January 23, 2023
Agilent, Quest extend access to NGS liquid biopsy CDx for NSCLC
The agreement between Agilent and Quest aims to enable broader adoption of ctDx First, a single-site premarket approved test performed at the Resolution Bioscience CLIA-certified laboratory in Kirkland, WA.
January 23, 2023
Qiagen launches molecular diagnostic platform for automated sample processing
The EZ2 Connect MDx uses a high level of automation to enable labs to purify DNA and RNA from 24 samples in parallel in 30 minutes.
January 18, 2023
Page 1 of 170
Next Page